Academic medicine's glass ceiling: Author's gender in top three medical research journals impacts probability of future publication success. by John E Krstacic, Brendan M Carr, Ashutosh R Yaligar, Annet S Kuruvilla, Joshua S Helali, Jamie Saragossi, Chencan Zhu, Robert Hutnik, Mohammad Noubani, Jie Yang, Henry J Tannous, A Laurie W Shroyer

“…Holding other factors constant, trends over time for significant author (i.e., first, second, last or any of these authors) publications were examined for the three highest-impact medical research journals (i.e., New England Journal of Medicine [NEJM], Journal of the American Medical Association [JAMA], and Lancet).…”
Get full text

A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data by Ping-Tee Tan, Suzie Cro, Eleanor Van Vogt, Matyas Szigeti, Victoria R. Cornelius

“…Methods A targeted review of phase II-IV RCTs (non-cluster randomised) published in two leading general medical journals (The Lancet and New England Journal of Medicine) between January 2014 and December 2019 using MI. …”
Get full text

Incorporation of randomized controlled trials into organizational guidelines for obstetricians and gynecologists by Rigoberto Gutierrez, Matthew Bicocca, Gregory Opara, Megha Gupta, Michal Fishel Bartal, Suneet P. Chauhan, Stephen Wagner

“…Methods: Original research articles published in The American Journal of Obstetrics and Gynecology, The Journal of the American Medical Association, The New England Journal of Medicine, and Obstetrics and Gynecology between 2009 and 2014 were examined and randomized controlled trials (RCT) in obstetrics and gynecology were identified. …”
Get full text

A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials by Elizabeth J. Conroy, Barbara Arch, Nicola L. Harman, J. Athene Lane, Steff C. Lewis, John Norrie, Matthew R. Sydes, Carrol Gamble

“…The cohort comprised RCTs published in three leading medical journals (the British Medical Journal, The Lancet and the New England Journal of Medicine) within 6 months in 2012 and the full NIHR HTA Monograph series. …”
Get full text

Development Of Type 1 Diabetes After Cancer Immunotherapy by Jennifer B. Hao, MD, Anas Renno, MD, Shahnawaz Imam, DVM, PhD, Maria Alfonso-Jaume, MD, Noha Elnagar, MD, PAC, Juan Carlos Jaume, MD

“…Development of type 1 diabetes as an adverse event was not documented in the New England Journal of Medicine article that introduced its successful use for melanoma treatment.Methods: We present the case of an adult patient who developed autoimmune diabetes after treatment with nivolumab, accompanied by the presence of high serum titers of glutamic acid decarboxylase 65 (GAD65) isoform antibodies and a clinical presentation of diabetic ketoacidosis.Results: Although endocrine autoimmunity has been described following treatment with nivolumab, type 1 diabetes has only been shown after the treatment of 2 patients with melanoma that happened to be antibody (GAD65, insulin, and islet cell antibody) negative.Conclusion: Clinicians prescribing this drug need to be aware of this life-threatening adverse effect. …”
Get full text

Variations in how medical researchers report patient demographics: a retrospective analysis of published articlesResearch in context by Erika E. Lynn-Green, Avery A. Ofoje, Robert H. Lynn-Green, David S. Jones

“…Methods: Original articles were included from issues of the New England Journal of Medicine (NEJM), JAMA, The Lancet, and the American Journal of Epidemiology (AJE) published from 1 January to 31 December 2020 (n = 640). …”
Get full text

Academic medicine’s glass ceiling: Author’s gender in top three medical research journals impacts probability of future publication success by John E. Krstacic, Brendan M. Carr, Ashutosh R. Yaligar, Annet S. Kuruvilla, Joshua S. Helali, Jamie Saragossi, Chencan Zhu, Robert Hutnik, Mohammad Noubani, Jie Yang, Henry J. Tannous, A. Laurie W. Shroyer

“…Holding other factors constant, trends over time for significant author (i.e., first, second, last or any of these authors) publications were examined for the three highest-impact medical research journals (i.e., New England Journal of Medicine [NEJM], Journal of the American Medical Association [JAMA], and Lancet). …”
Get full text

Review and Analysis of Publication Trends over Three Decades in Three High Impact Medicine Journals. by Alexander Ivanov, Beata A Kaczkowska, Saadat A Khan, Jean Ho, Morteza Tavakol, Ashok Prasad, Geetha Bhumireddy, Allan F Beall, Igor Klem, Parag Mehta, William M Briggs, Terrence J Sacchi, John F Heitner

“…Financial incentives can lead to potential conflicts of interest (COI) resulting in underreporting of negative study results.We hypothesized that over the three decades, there would be an increase in: a) reporting of conflict of interest and source of funding; b) percentage of randomized control trials c) number of patients per study and d) industry funding.Original articles published in three calendar years (1988, 1998, and 2008) in The Lancet, New England Journal of Medicine and Journal of American Medical Association were collected.Studies were reviewed and investigational design categorized as prospective and retrospective clinical trials. …”
Get full text

Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study by Duca Piergiorgio, Luchetta Maria, Casazza Giovanni, Bonacini Maria, Montedori Alessandro, Cozzolino Francesco, Abraha Iosief

“…</p> <p>Methods</p> <p>To determine differences in the methodological quality, sponsorship, authors' conflicts of interest, and findings among trials with different "types" of intention-to-treat, we undertook a cross-sectional study of RCTs published in 2006 in three general medical journals (the Journal of the American Medical Association, the New England Journal of Medicine and the Lancet) and three specialty journals (Antimicrobial Agents and Chemotherapy, the American Heart Journal and the Journal of Clinical Oncology). …”
Get full text

Prevention and Management of Operating Room Fire: An Interprofessional Operating Room Team Simulation Case by Christine L. Mai, Praelada Wongsirimeteekul, Emil Petrusa, Rebecca Minehart, Maureen Hemingway, May Pian-Smith, Ersne Eromo, Roy Phitayakorn

Get full text

Citações nos artigos publicados na revista portuguesa de clínica geral: Análise da década 2000-2009 by Maria Da Luz Antunes

“…Nas revistas mais citadas são identificados três títulos (New England Journal of Medicine, Lancet e JAMA) posicionados no ranking de análise do factor de impacto junto da comunidade científica. …”
Get full text

Revisiting Jacobson by Henry Curtis

“…Massachusetts" New England Journal of Medicine352, no. 7 (2005): 652-654. [6] Fidler, David, Lawrence Gostin, and Howard Markel. …”
Get full text

Tendencia de publicación de ensayos clínicos con resultados negativos financiados por industrias farmacéuticas durante el periodo 2007-2012 by Evert A. Jiménez-Cotes, Laura Mejía-Cardona, Jorge H. Donado-Gómez

“…Materiales y métodos: Se realizó un estudio observacional de corte transversal donde se revisaron ensayos clínicos originales financiados por la industria farmacéutica publicados entre el año 2007 y 2012 en la revista The New England Journal of Medicine (http://www.nejm.org). Se empleó la prueba de Chi2 de tendencia para evaluar los resultados de los estudios a través de los años. …”
Get full text

Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis by Yanhao Liu, Yanhao Liu, Xu Cheng, Xiaona Han, Xi Cheng, Shu Jiang, Yaru Lin, Zhen Zhang, Linlin Lu, Baozhen Qu, Yuxian Chen, Xiaotao Zhang

“…Among the journals, New England Journal of Medicine was most influential. Corresponding authors represented China took part in most articles (904) and papers with corresponding authors from the USA were most cited (139.46 citations per paper). …”
Get full text

Neurotrauma Research in Latin America by Andrés Rubiano, Angela Rios

“…Recently a study performed in Ecuador, Argentina and Bolivia, published in the New England Journal of Medicine, generated international controversy due to the implications of their results in the treatment protocols of severe head trauma.3 After deep analysis of the results of this study in several meetings of traumatic brain injury experts and after extensive academic discussions published in different biomedical journals, it was considered that this study, with a very good methodological approach, failed trying to understand the ecology of the medical management in environments with slightly different views of advanced care.4-8 These patients were managed under non traditional high income health care settings; due to this, interpretation of advanced monitoring to generate intervention decisions, could be influenced by the idiosyncrasies and pre-existing conditions in different health systems and training resources. …”
Get full text

Plain language summary: clinical trial of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis by Luca Richeldi, Arata Azuma, Vincent Cottin, Christian Hesslinger, Susanne Stowasser, Claudia Valenzuela, Marlies S Wijsenbeek, Donald F Zoz, Florian Voss, Toby M Maher

“…This plain language summary describes the main findings from a trial in people with idiopathic pulmonary fibrosis (also called IPF) that was recently published in the New England Journal of Medicine. IPF is a rare disease, where the lungs become more and more scarred, with breathing and oxygen uptake becoming increasingly difficult. …”

Gender-gap in randomized clinical trials reporting mortality in the perioperative setting and critical care: 20 years behind the scenes by Carolina S. Romero, Nicolò Maimeri, Alessandra Bonaccorso, Martina Baiardo-Redaelli, Gaetano Lombardi, Otito Frances Iwuchukwu, Alessandro Ortalda, Benedikt Schmid, Magdalena Fleming, Giovanni Landoni

“…The median impact factor of the target journal was 6 (3-27) in women vs. 7 (3-28) in men, with a p-value of 0.67; Critical Care Medicine, JAMA, and The New England Journal of Medicine were the most frequent target journals for both women and men. …”
Get full text

LEGALIZING SAME-SEX MARRIAGE: RECONSIDER ITS CONSEQUENCES by Habibullah Khan, Shaukat Ali, Iftikhar Ahmad, Atta Ilahi

“…A perspective by Gonzales and later an editorial by Campion et al, both in the world’s leading medical journal, The New England Journal of Medicine, depicted a one-sided picture to make the case in favor of same-sex marriages. …”
Get full text

Reducing the risks of nuclear war—The role of health professionals by Kamran Abbasi, Parveen Ali, Virginia Barbour, Kirsten Bibbins-Domingo, Marcel GM Olde Rikkert, Andy Haines, Ira Helfand, Richard Horton, Robert Mash, Arun Mitra, Carlos Monteiro, Elena N. Naumova, Eric J. Rubin, Tilman Ruff, Peush Sahni, James Tumwine, Paul Yonga, Chris Zielinski

Get full text

Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology by Craig L. Cambridge, Emily Stern Gatof, Glen J. Weiss, Roger B. Davis

“…-based academic authors (authors) of industry-sponsored solid tumor clinical trials published between August 1, 2014, and December 31, 2015, in 6 high-impact journals (New England Journal of Medicine, Nature, Science, Lancet Oncology, Journal of Clinical Oncology, and Cancer Discovery) was assembled. …”
Get full text